Allogene Therapeutics (ALLO) Q3 2026 Earnings

5AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-0.27
-0.24
-0.2
-0.17

Details

Expected EPS
-0.169723
Actual EPS
N/A
Surprise EPS
0.17
Surprise Percent
+100%

Description

Allogene Therapeutics (ALLO) will report earnings of for Q3 2026 on August 05, 2026.

0 Comments

Share your thoughts